T cell engagers are an exciting area of immunotherapy that remains in the early innings of development. We believe gamma-delta T cells offer unique properties, including tissue residence, phagocytosis ...
The cells could combine the advantages of conventional T cells, which express alpha and beta TCR chains, with receptors derived from gamma delta T-cells that recognise novel targets in cancers cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback